SCHEMBL6500202

SCHEMBL6500202

NC(=O)Nc1cn(-c2ccc(Sc3ccc(F)cc3)cc2F)nc1C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITK Q08881 1/20 0.43
PARP1 P09874 1/20 0.37
ALDH1A1 P00352 2/20 0.34
CYP1A2 P05177 2/20 0.33
CYP2C9 P11712 2/20 0.33
CYP2C19 P33261 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
NPSR1 Q6W5P4 3/20 0.33
CYP3A4 P08684 1/20 0.33
GAA P10253 1/20 0.33
CYP2D6 P10635 1/20 0.33
HPGD P15428 1/20 0.33
KIF11 P52732 2/20 0.33
MAP2K2 P36507 1/20 0.33
MAP2K1 Q02750 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.33
MAPK14 Q16539 2/20 0.32
LRRK2 Q5S007 1/20 0.32
KDM4E B2RXH2 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6470399 0.89 ITK (0.44) ITKPARP1ALDH1A1CYP1A2CYP2C9
SCHEMBL6506908 0.89 ITK (0.42) ITKPARP1ALDH1A1CYP1A2CYP2C9
SCHEMBL6465915 0.87 ITK (0.44) ITKPARP1KIF11MAP2K2MAP2K1
SCHEMBL6470631 0.85 KDM4E (0.42) ITKPARP1ALDH1A1CYP1A2CYP2C9
SCHEMBL6507064 0.82 ITK (0.43) ITKPARP1ALDH1A1KIF11
SCHEMBL6468649 0.80 ITK (0.43) ITKPARP1ALDH1A1CYP1A2CYP2C9
SCHEMBL6467527 0.77 KDM4E (0.47) ITKPARP1ALDH1A1MEN1KMT2A
SCHEMBL6506095 0.77 ITK (0.39) ITKPARP1ALDH1A1HPGDMAPK14
SCHEMBL6465878 0.77 ITK (0.37) ITKPARP1ALDH1A1MEN1KMT2A
SCHEMBL6478539 0.76 ITK (0.43) ITKPARP1CYP3A4KIF11IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation PHARMACIA AND UPJOHN COMPANY LLC 2005-09-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050197338-A1 Substituted pyrazole urea compounds for the treatment of inflammation IL4, ARG2, CASP4 ITK 4236/4885PARP1 1904/4885ALDH1A1 846/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.